Deletions and rearrangements of cyclin-dependent kinase 4 inhibitor gene p16 are associated with poor prognosis in B cell non-Hodgkin's lymphomas

Leukemia

Volumn 11, Issue 11, 1997, Pages 1915-1920

  Garcia Sanz R ^a   Gonzalez M ^a   Vargas, M ^a   Chillon M C ^a   Balanzategui, A ^a   Barbon M ^a   Flores, M T ^a   San Miguel, J F ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Deletion; Lymphoma; p16 tumor suppressor gene; Prognosis; Rearrangement

Indexed keywords

BETA 2 MICROGLOBULIN; CYCLIN DEPENDENT KINASE INHIBITOR; LACTATE DEHYDROGENASE; PROTEIN P16;

ARTICLE; CANCER GENETICS; CANCER SURVIVAL; GENE DELETION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; LYMPHOCYTOMA; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; MULTIVARIATE ANALYSIS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

EID: 0030687951     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400833     Document Type: Article

References (14)

1. Korsmeyer SJ. Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. Annu Rev Immunol 1992; 10: 785-807.
2. Offit K, Parsa NZ, Jhanwar SC, Filippa D, Watchel M, Chaganti RSK. Clusters of chromosome 9 aberrations are associated with clinico-pathologic subsets of non-Hodgkinis lymphoma. Genes Chromosom Cancer 1993; 7: 1-7.
3. Johansson B, Mertens F, Mitelman F. Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci. Genes Chromosom Cancer 1993; 8: 205-218.
4. Rabitts TH. Chromosomal translocations in human cancer. Nature 1994; 372: 143-149.
5. Hirama T, Koefler HP. Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 1995; 86: 841-854.
6. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK 4. Nature 1994; 366: 704-707.
7. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995; 9: 1149-1163.
8. Xiong Y, Zhang H, Beach D. D-type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 1992; 71: 505-514.
9. Xiong Y, Zhang H, Beach D. Subunit rearrangement of cyclin-dependent kinases is associated with cellular transformation. Genes Dev 1993; 7: 1572-1583.
10. Sherr CJ. Mammalian G1 cyclins. Cell 1993; 73: 1059-1065.
11. Arap W, Nishikawa R, Furnari FB, Cavene WK, Suttuang H-J. Replacement of the p16/CDKN2 gene suppresses human glioma cell growth. Cancer Res 1995; 55: 1351-1354.
12. Herbert J, Cayuela JM, Berkeley J, Sigaux F. Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T but not from B cell lineage acute lymphoblastic leukemias. Blood 1994; 84: 4038-4044.
13. Ogawa S, Hirano N, Sato N, Takahasi T, Hangaishi A, Tanaka K, Kurokawa M, Tanaka T, Mitani K, Yazaki Y, Hirai H. Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemia. Blood 1994; 84: 2431-2435.
14. Quesnel B, Preudhomme C, Philippe N, Vanrumbeke M, Dervite I, Lai JL, Bauters F, Wattel E, Fenaux P. p16 gene homozygous deletions in acute lymphoblastic leukemia. Blood 1995; 65: 657-663.